Table 4.
First author | No of cases | Anemia Cut Off | Outcome | Other Studies | Ours | ||
---|---|---|---|---|---|---|---|
HR(95%CI) | p-value | HR(95%CI) | p-value | ||||
Holgersson et al38 | 835 | <11g/dL | OS | 1.33(1.10,1.61) | 0.003 | 1.3 (1.0, 1.7) | 0.059 |
Pathak et al9 | 752 | <12 g/dL | OS | 1.51(1.03,2.21) | 0.030 | 1.4 (1.1, 1.8) | 0.002 |
Belbaraka et al11 | 45 | male<13g/dL, | OS | 2.78(1.29,5.99) | 0.009 | 1.4 (1.1, 1.9) | 0.009 |
female<11.5g/dL. | |||||||
Park et al13 | 630 | male<13g/dL, | OS | 1.31(1.03,1.68) | 0.030 | 1.4 (1.1, 1.7) | 0.004 |
female<12g/dL. |
Our cohort were adjusted for: Age; Sex; Smoking history; ECOG PS; BMI; Pathology; Differentiation; ALK fusion; EGFR mutation; Sum of metastasis organs; Treat type of 1st line therapy; Sum of treatment lines.